Related Experiment Video
Updated: May 24, 2026
10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Diabetic macular edema: therapeutic options
Amol D Kulkarni1, Michael S Ip
1Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Summary
New treatments for diabetic macular edema (DME) are emerging. This review compares intravitreal antivascular endothelial growth factor medications and corticosteroids against the historical standard of focal laser photocoagulation for DME.
Area of Science:
- Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
- Focal laser photocoagulation is the traditional treatment for DME.
- Emerging pharmacologic therapies offer new treatment avenues.
Purpose of the Study:
- To review and compare current treatment options for diabetic macular edema.
- To analyze recent clinical trial data for DME therapies.
- To provide an overview of evolving DME treatment strategies.
Main Methods:
- Literature review of recent clinical trials and studies.
- Comparative analysis of treatment efficacy and safety profiles.
- Synthesis of data on intravitreal medications and corticosteroids versus laser therapy.
Main Results:
- Intravitreal antivascular endothelial growth factor medications and corticosteroids show significant promise in recent studies.
- These newer therapies demonstrate potential for improved visual outcomes compared to historical treatments.
- Data highlights the evolving landscape of DME management.
Conclusions:
- Pharmacologic therapies, particularly intravitreal injections, represent a significant advancement in DME treatment.
- A shift from traditional laser photocoagulation towards pharmacologic interventions is evident.
- Further research and clinical trials continue to refine DME management strategies.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...